Medtronic to market Powerheart hospital monitor:
This article was originally published in Clinica
Medtronic Physio-Control is to market Cardiac Science's Powerheart fully automatic hospital bedside defibrillator-monitor in the US and Canada. Medtronic has also gained an exclusive licence for the Irvine, California-based company's proprietary tachyarrhythmia detection and discrimination software. Medtronic will integrate the software into existing and future LIFEPAK defibrillator/monitor products for the US and Canadian hospital market. Medtronic Physio-Control is Medtronic's defibrillator division - formed after Medtronic's acquisition of Physio-Control earlier this year.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.